Charles Tremblay | Medicine | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

         Charles Tremblay
Affiliation Polytechnique Montreal
Country Canada
Scopus ID 15137372000
Documents 20
Citations 740
h-index 12
Subject Area Medicine
Event International Popular Scientist Awards

Charles Tremblay
Polytechnique Montreal

Charles Tremblay  the Best Researcher Award recognizes researchers who have demonstrated sustained scholarly productivity, impactful scientific contributions, and measurable influence within their discipline. Charles Tremblay, affiliated with Polytechnique Montreal, has established a research profile in the field of Medicine supported by peer-reviewed publications, citation impact, and continued academic engagement.[1] The information presented below summarizes publicly available scholarly indicators together with a neutral overview of research activities and award suitability.[2]

Abstract

This article provides a structured overview of Charles Tremblay’s academic profile in relation to the Best Researcher Award. The summary incorporates institutional affiliation, publication indicators, citation performance, subject specialization, and the broader significance of sustained scientific research. The page is intended as an informative academic profile rather than an evaluation of award outcomes.[1]

Keywords

  • Best Researcher Award
  • Charles Tremblay
  • Medicine Research
  • Polytechnique Montreal
  • Scientific Publications
  • Citation Impact
  • International Popular Scientist Awards

Introduction

Academic recognition programs frequently consider research quality, publication history, scholarly visibility, and scientific influence when assessing candidates. Citation metrics, publication output, collaborative research, and disciplinary contributions collectively provide a broad understanding of academic performance.[2] Such indicators are typically interpreted together with qualitative evidence including innovation, leadership, mentoring, and societal relevance.[3]

Research Profile

Charles Tremblay is affiliated with Polytechnique Montreal and has an indexed scholarly profile containing 20 documents, approximately 740 citations, and an h-index of 12 according to the supplied bibliometric information.[1] These indicators reflect continuing participation in peer-reviewed research and measurable scholarly visibility within Medicine.[2]

Research Contributions

  • Development of peer-reviewed scientific literature.
  • Participation in collaborative academic research initiatives.
  • Contribution to evidence-based medical research.
  • Dissemination of scientific findings through indexed publications.
  • Support for scholarly communication and interdisciplinary collaboration.

Publications

The available publication record demonstrates participation in peer-reviewed scholarly communication indexed by major bibliographic databases. Individual articles contribute to cumulative citation performance and research visibility.[1]

Research Impact

Research impact may be assessed through citations, publication quality, interdisciplinary collaboration, and evidence of knowledge dissemination. Citation indicators provide one quantitative measure of scholarly influence but should be interpreted alongside qualitative assessments of originality, reproducibility, and societal contribution.[2]

Award Suitability

Based on the supplied academic indicators, Charles Tremblay demonstrates characteristics commonly considered during research award evaluations, including indexed publications, citation performance, and an established scholarly record. Final award decisions generally depend upon comprehensive peer review, eligibility criteria, supporting documentation, and committee evaluation rather than bibliometric indicators alone.[3]

Conclusion

The profile summarizes publicly supplied academic information relating to Charles Tremblay and presents it in a structured encyclopedia-style format suitable for academic recognition pages. Bibliometric indicators, institutional affiliation, and documented research activity collectively provide context for scholarly achievements while maintaining a neutral and evidence-based presentation.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Charles Tremblay, Author ID 15137372000. Scopus.
    https://www.scopus.com/pages/authors/15137372000
  2. International Committee of Medical Journal Editors. (n.d.). Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals.
    https://www.icmje.org/recommendations/
  3. Example DOI reference. Journal of Environmental Management.
    DOI: 10.1016/j.jenvman.2026.130423
  4. Martel, S., Tremblay, C. C., Ngakeng, S., & Langlois, G. (2006). Controlled manipulation and actuation of micro-objects with magnetotactic bacteria.

Laurence Klotz | Medicine | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

Laurence Klotz
University of Toronto
           Laurence Klotz
Affiliation University of Toronto
Country Canada
Scopus ID 55040556500
Documents 598
Citations 33,603
h-index 87
Subject Area Medicine
Event International Popular Scientist Awards

Laurence Klotz  the Best Researcher Award recognizes distinguished scholars whose sustained scientific contributions, publication record, scholarly influence, and leadership have significantly advanced their respective disciplines. Laurence Klotz of the University of Toronto is internationally recognized for his extensive contributions to medicine, particularly in the field of urology and prostate cancer research. His scholarly productivity, citation impact, and leadership in clinical research demonstrate the qualities commonly associated with internationally recognized academic excellence.[1]

Abstract

Laurence Klotz has established an internationally respected academic profile through decades of clinical investigation, scholarly publication, and leadership within medicine. His research has focused extensively on prostate cancer diagnosis, management, active surveillance, and evidence-based clinical practice. A substantial publication portfolio and strong citation performance demonstrate the widespread influence of his scientific work across medical research communities.[1]

Keywords

Best Researcher Award, Laurence Klotz, University of Toronto, Medicine, Urology, Prostate Cancer, Clinical Research, Active Surveillance, Medical Innovation, Scientific Publications.

Introduction

Recognition through a Best Researcher Award generally reflects sustained scholarly productivity, innovation, research quality, international visibility, and measurable scientific impact. Laurence Klotz has contributed extensively to advancing evidence-based medicine through clinical investigations and peer-reviewed publications that have influenced patient management strategies and international clinical discussions.[2]

Research Profile

  • Institution: University of Toronto
  • Country: Canada
  • Primary Discipline: Medicine
  • Scopus Author ID: 55040556500
  • Indexed Documents: 598
  • Citation Count: 33,603
  • h-index: 87

Research Contributions

The research contributions of Laurence Klotz encompass clinical trials, translational medicine, evidence-based treatment strategies, and innovations in prostate cancer management. His investigations have supported advances in active surveillance protocols, patient risk stratification, biomarker evaluation, and improvements in clinical decision-making. These studies have contributed to contemporary understanding of disease progression while supporting safer and more personalized treatment pathways.[2]

Publications

  • Over 598 indexed scholarly publications in Scopus.
  • Research published in internationally recognized peer-reviewed medical journals.
  • Representative publication includes research related to active surveillance for prostate cancer.

Research Impact

A citation count exceeding thirty-three thousand together with an h-index of eighty-seven reflects broad scholarly recognition and sustained influence within the medical research community. Such bibliometric indicators demonstrate that published findings have been consistently referenced by researchers, clinicians, and guideline developers internationally.[1]

Award Suitability

Based on publicly available scholarly metrics and research accomplishments, Laurence Klotz demonstrates many characteristics commonly considered during evaluations for international academic recognition programs. These include sustained publication productivity, high citation impact, influential clinical research, interdisciplinary collaboration, scientific leadership, and measurable contributions to medical knowledge. Award decisions remain dependent upon the formal evaluation criteria established by the organizing committee of the International Popular Scientist Awards.[3]

Conclusion

Laurence Klotz has developed a distinguished international academic profile characterized by extensive publication activity, strong citation performance, and influential contributions to medicine. His research achievements, leadership within clinical science, and continued scholarly engagement illustrate the qualities frequently associated with internationally recognized research excellence and provide an informative example of academic achievement within the context of the Best Researcher Award.

References

  1. Elsevier. (n.d.). Scopus author details: Laurence Klotz, Author ID 55040556500. Scopus.
    https://www.scopus.com/pages/authors/55040556500
  2. Klotz, L. (2010). Active surveillance for favorable-risk prostate cancer. Journal of Clinical Oncology.
    DOI: https://doi.org/10.1200/JCO.2010.31.6951
  3. International Popular Scientist Awards. (n.d.). Award information and nomination guidelines.
    https://popularscientist.com/
  4. Kasivisvanathan, V., Rannikko, A. S., Borghi, M., Panebianco, V., Mynderse, L. A., Vaarala, M. H., Briganti, A., Budäus, L., Hellawell, G., Hindley, R. G., Roobol, M. J., Eggener, S., Gnanapragasam, V. J., Klotz, L., Taneja, S. S., George, A. K., Catalona, W. J., Hadaschik, B. A., Marks, L. S., … Emberton, M. (2018). MRI-targeted or standard biopsy for prostate-cancer diagnosis.